Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-12 19:17:39 UTC |
---|
Update Date | 2023-02-21 17:16:37 UTC |
---|
HMDB ID | HMDB0003355 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Aminopentanoic acid |
---|
Description | 5-Aminopentanoic acid (or 5-aminovalerate) is a lysine degradation product. It can be produced both endogenously or through bacterial catabolism of lysine. 5-aminovalerate is formed via the following multi-step reaction: L-lysine leads to cadverine leads to L-piperideine leads 5-aminovalerate (PMID:405455 ). In other words it is a metabolite of cadaverine which is formed via the intermediate, 1-piperideine (PMID:6436440 ). Cadaverine is a foul-smelling diamine compound produced by protein hydrolysis during putrefaction of animal tissue. High levels of 5-aminovalerate in biofluids may indicate bacterial overgrowth or endogenous tissue necrosis. In most cases endogenous 5-aminovalerate is thought to be primarily a microbial metabolite produced by the gut or oral microflora, although it can be produced endogenously. 5-aminovalerate is a normal metabolite present in human saliva, with a tendency to elevated concentration in patients with chronic periodontitis. Bacterial contamination and decomposition of salivary proteins is primarily responsible for elevated salivary levels (PMID 3481959 ). Beyond being a general waste product, 5-aminovalerate is also believed to act as a methylene homologue of gamma-aminobutyric acid (GABA) and functions as a weak GABA agonist (PMID:4031870 ). It is also known as an antifibrinolytic amino acid analog and so it functions as a weak inhibitor of the blood clotting pathway (PMID:6703712 ). 5- aminovalerate is an in vivo substrate of 4-aminobutyrate:2-oxoglutarate aminotransferase (PMID:4031870 ). It can be found in Corynebacterium (PMID:27717386 ). |
---|
Structure | InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8) |
---|
Synonyms | Value | Source |
---|
5-Amino-N-valeric acid | ChEBI | 5-Aminopentanoate | ChEBI | 5-Aminovaleric acid | ChEBI | DANVA | ChEBI | delta-Amino-N-valeric acid | ChEBI | delta-Aminovaleric acid | ChEBI | 5-Amino-N-valerate | Generator | 5-Aminovalerate | Generator | delta-Amino-N-valerate | Generator | Δ-amino-N-valerate | Generator | Δ-amino-N-valeric acid | Generator | delta-Aminovalerate | Generator | Δ-aminovalerate | Generator | Δ-aminovaleric acid | Generator | 5-Aminovaleric acid hydrochloride | MeSH | 5-Aminopentanoic acid | KEGG | 5-Amino-pentanoate | Generator, HMDB |
|
---|
Chemical Formula | C5H11NO2 |
---|
Average Molecular Weight | 117.1463 |
---|
Monoisotopic Molecular Weight | 117.078978601 |
---|
IUPAC Name | 5-aminopentanoic acid |
---|
Traditional Name | 5-aminovaleric acid |
---|
CAS Registry Number | 660-88-8 |
---|
SMILES | NCCCCC(O)=O |
---|
InChI Identifier | InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8) |
---|
InChI Key | JJMDCOVWQOJGCB-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as delta amino acids and derivatives. Delta amino acids and derivatives are compounds containing a carboxylic acid group and an amino group at the C5 carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Delta amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Delta amino acid or derivatives
- Straight chain fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 157.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1000 mg/mL at 20 °C | Not Available | LogP | -2.63 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Aminopentanoic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCN | 1221.1 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,1TMS,isomer #2 | C[Si](C)(C)NCCCCC(=O)O | 1350.5 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #1 | C[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C | 1390.2 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #1 | C[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C | 1490.7 | Standard non polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #1 | C[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C | 1539.6 | Standard polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #2 | C[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C | 1580.3 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #2 | C[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C | 1524.2 | Standard non polar | 33892256 | 5-Aminopentanoic acid,2TMS,isomer #2 | C[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C | 1788.9 | Standard polar | 33892256 | 5-Aminopentanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C)[Si](C)(C)C | 1641.4 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C)[Si](C)(C)C | 1614.2 | Standard non polar | 33892256 | 5-Aminopentanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C)[Si](C)(C)C | 1541.5 | Standard polar | 33892256 | 5-Aminopentanoic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCN | 1441.4 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCCCC(=O)O | 1601.5 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C(C)(C)C | 1861.5 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C(C)(C)C | 1856.7 | Standard non polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCC(=O)O[Si](C)(C)C(C)(C)C | 1792.8 | Standard polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C(C)(C)C | 2004.5 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C(C)(C)C | 1920.2 | Standard non polar | 33892256 | 5-Aminopentanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CCCCC(=O)O)[Si](C)(C)C(C)(C)C | 1930.8 | Standard polar | 33892256 | 5-Aminopentanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2279.4 | Semi standard non polar | 33892256 | 5-Aminopentanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2189.5 | Standard non polar | 33892256 | 5-Aminopentanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1920.7 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-00di-1900000000-37b43ab4ca79d55eaf25 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (3 TMS) | splash10-00fr-3910000000-9345963250dd5bb94624 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid EI-B (Non-derivatized) | splash10-0536-9000000000-5adf6445ea3955b657bd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid EI-B (Non-derivatized) | splash10-00di-0910000000-74bd5c8746b39b3c0420 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-EI-TOF (Non-derivatized) | splash10-00di-1900000000-37b43ab4ca79d55eaf25 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (Non-derivatized) | splash10-00fr-3910000000-9345963250dd5bb94624 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-EI-TOF (Non-derivatized) | splash10-00di-1900000000-f11968cc499179c1c6dc | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-EI-TOF (Non-derivatized) | splash10-00dr-4900000000-3ea14dbac57e0143438f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Aminopentanoic acid GC-EI-TOF (Non-derivatized) | splash10-0fe0-4920000000-3f3f703bde631395004a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9000000000-4e782590c46224696321 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-0fk9-9700000000-88ec0b1d4be9919f59a4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminopentanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0udi-1900000000-2defcb7a4884b3297cac | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0f89-9500000000-5fd8b1ba2492405b08ef | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0gb9-3900000000-0afcdbe5370c811ffcaa | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-014i-0900000000-7ac1f98cc9b9752a76d6 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-014i-0900000000-f5c899766b4d912df5ce | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-014i-0900000000-5e5ee374be357b4e26a4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0gb9-0900000000-969dd1eb59619aa0cf7a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0zfr-9700000000-fe04f26630dfb11c0ca0 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0a4i-9000000000-fe2ccbb2c7e8d2912ff5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0a4i-9000000000-58e7344ed5410bdb1ae7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-0a4i-9000000000-3f1c0f186d2397481f21 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-0udi-1900000000-17b2a3b2a8a744b197fc | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-014i-0900000000-dfd5e0188b9d032c50c5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ , negative-QTOF | splash10-014i-0900000000-7ac1f98cc9b9752a76d6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ , negative-QTOF | splash10-014i-0900000000-f5c899766b4d912df5ce | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ , negative-QTOF | splash10-014i-0900000000-5e5ee374be357b4e26a4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QTOF , negative-QTOF | splash10-014i-0900000000-dfd5e0188b9d032c50c5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ , positive-QTOF | splash10-0gb9-0900000000-969dd1eb59619aa0cf7a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Aminopentanoic acid LC-ESI-QQ , positive-QTOF | splash10-0zfr-9700000000-fe04f26630dfb11c0ca0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 10V, Positive-QTOF | splash10-0udi-2900000000-36fcf52a7600d383116c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 20V, Positive-QTOF | splash10-0zgi-9600000000-e0d24cc72e765633ef93 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 40V, Positive-QTOF | splash10-0a4l-9000000000-177c4dd0230c5c481274 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 10V, Negative-QTOF | splash10-014i-4900000000-50c9e3e40bbc639d1f2e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 20V, Negative-QTOF | splash10-01ba-9500000000-f55ea028ca0fae6c620b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminopentanoic acid 40V, Negative-QTOF | splash10-0a4l-9000000000-83bf020782f77c2d4ef7 | 2017-09-01 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Not Available | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Both | Normal | | details | Feces | Detected and Quantified | 262.0655 +/- 254.383 nmol/g wet feces | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 74.2 +/- 1.05×102 uM | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 119 +/- 93.3 uM | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 470.38 +/- 342.79 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.10 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.0-1.2 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.98-1.2 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 2 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.1 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Periodontal Probing Depth | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Supragingival Calculus | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Supragingival Plaque | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Irritable bowel syndrome |
---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
| Ulcerative colitis |
---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
- Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9. [PubMed:28842642 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Periodontal Probing Depth |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Supragingival Calculus |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Supragingival Plaque |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023151 |
---|
KNApSAcK ID | C00052162 |
---|
Chemspider ID | 135 |
---|
KEGG Compound ID | C00431 |
---|
BioCyc ID | 5-AMINOPENTANOATE |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 6902 |
---|
PubChem Compound | 138 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 15887 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 5APTN |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Allan, Robin D.; Dickenson, Helena W.; Johnston, Graham A. R.; Kazlauskas, Rymantas; Tran, Hue W. Synthesis of analogs of GABA. XIV. Synthesis and activity of unsaturated derivatives of 5-aminopentanoic acid (d-aminovaleric acid). Australian Journal of Chemistry (1985), 38(11), 1651-6. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E, Vernillet L, Risse ML, Boige V, Gouyette A, Vassal G: Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans. Clin Cancer Res. 2000 May;6(5):2012-20. [PubMed:10815927 ]
- Sparreboom A, de Jonge MJ, de Bruijn P, Brouwer E, Nooter K, Loos WJ, van Alphen RJ, Mathijssen RH, Stoter G, Verweij J: Irinotecan (CPT-11) metabolism and disposition in cancer patients. Clin Cancer Res. 1998 Nov;4(11):2747-54. [PubMed:9829738 ]
- Fujita K, Ando Y, Narabayashi M, Miya T, Nagashima F, Yamamoto W, Kodama K, Araki K, Endo H, Sasaki Y: Gefitinib (Iressa) inhibits the CYP3A4-mediated formation of 7-ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin but activates that of 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino]carbonyloxycamptothecin from irinotecan. Drug Metab Dispos. 2005 Dec;33(12):1785-90. Epub 2005 Aug 25. [PubMed:16123050 ]
- Poujol S, Pinguet F, Malosse F, Astre C, Ychou M, Culine S, Bressolle F: Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies. Clin Chem. 2003 Nov;49(11):1900-8. [PubMed:14578322 ]
- van den Berg GA, Nagel GT, Muskiet FA, Halie MR: Mass fragmentographic identification of polyamine metabolites in the urine of normal persons and cancer patients, and its relevance to the use of polyamines as tumour markers. J Chromatogr. 1985 May 3;339(2):223-31. [PubMed:4008565 ]
- Syrjanen S, Piironen P, Markkanen H: Free amino-acid content of wax-stimulated human whole saliva as related to periodontal disease. Arch Oral Biol. 1987;32(9):607-10. [PubMed:3481959 ]
- Fothergill JC, Guest JR: Catabolism of L-lysine by Pseudomonas aeruginosa. J Gen Microbiol. 1977 Mar;99(1):139-55. [PubMed:405455 ]
- Callery PS, Geelhaar LA: Biosynthesis of 5-aminopentanoic acid and 2-piperidone from cadaverine and 1-piperideine in mouse. J Neurochem. 1984 Dec;43(6):1631-4. [PubMed:6436440 ]
- Callery PS, Geelhaar LA: 1-Piperideine as an in vivo precursor of the gamma-aminobutyric acid homologue 5-aminopentanoic acid. J Neurochem. 1985 Sep;45(3):946-8. [PubMed:4031870 ]
- Cole KR, Castellino FJ: The binding of antifibrinolytic amino acids to kringle-4-containing fragments of plasminogen. Arch Biochem Biophys. 1984 Mar;229(2):568-75. [PubMed:6703712 ]
- Shin JH, Park SH, Oh YH, Choi JW, Lee MH, Cho JS, Jeong KJ, Joo JC, Yu J, Park SJ, Lee SY: Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid. Microb Cell Fact. 2016 Oct 7;15(1):174. doi: 10.1186/s12934-016-0566-8. [PubMed:27717386 ]
|
---|